Y90 Dosing
Effective 7 September 2026 · Last updated 7 September 2026
Read this before using the app
Y90 Dosing is an educational reference tool for qualified healthcare professionals. It is not a medical device, it is not cleared or approved by any regulatory authority, and it must not be used as the sole basis for any clinical decision. Every result must be independently verified before it informs patient care.
These Terms of Use and End User License Agreement ("Agreement") are a binding agreement between you and Abhishek Goswami ("Developer", "we", "us") governing your use of the iOS application Y90 Dosing ("the App").
When you first open the App, it presents a summary of this Agreement and requires you to accept it before the App can be used. By accepting that summary, or by otherwise downloading, installing, or using the App, you agree to this Agreement in full, including the terms set out here that are not restated in the in-app summary.
If you do not agree, do not use the App, and delete it from your device.
Subject to your compliance with this Agreement, we grant you a limited, personal, non-exclusive, non-transferable, non-sublicensable, revocable license to install and use the App on an Apple-branded device that you own or control, for your own educational and professional reference purposes, as permitted by the App Store Terms of Service.
This is a license, not a sale. All rights not expressly granted are reserved.
The App is an educational and informational reference tool. It performs arithmetic on values that you enter, using published dosimetry formulations, and displays the result.
The Developer is an independent individual and is not affiliated with, endorsed by, sponsored by, or in any way connected to Boston Scientific Corporation, Sirtex Medical Limited, or any other manufacturer, distributor, or vendor of yttrium-90 microsphere products.
TheraSphere® is a registered trademark of Boston Scientific Corporation or its affiliates. SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd. Those names, and any other product or company name that appears in the App or in this Agreement, are used solely to identify the product to which a published calculation applies. Such use does not imply any association, sponsorship, or endorsement.
The App implements methods, constants, and thresholds drawn from publicly available sources — peer-reviewed literature, published regulatory text, and the manufacturers' own publicly available labeling. The Developer has no access to proprietary manufacturer data and receives no support, information, funding, or compensation from any manufacturer.
The App is intended for use only by qualified healthcare professionals who are trained and credentialed in radioembolization and who are capable of independently evaluating its output.
You agree that:
The App is not a HIPAA-compliant system and provides no safeguards suitable for protected health information. You agree not to enter patient names, medical record numbers, dates of birth, or any other individually identifying information into the App. You are solely responsible for any information you choose to enter and for any consequences of doing so.
We have made reasonable efforts to implement published methods correctly and to test them. Nevertheless, software may contain errors, published constants and thresholds may change, and product labeling may be revised. We do not warrant that the App is free of defects or that its output is correct, current, or suitable for any particular case. The App is provided for reference only and its output is not a substitute for independent calculation and verification.
You may not: copy, modify, translate, or create derivative works of the App; reverse engineer, decompile, or disassemble the App except to the extent that applicable law expressly permits despite this limitation; rent, lease, lend, sell, redistribute, or sublicense the App; remove or obscure any proprietary notice or disclaimer; or use the App in any manner that violates applicable law or professional obligation.
The App, including its source code, design, text, and all other content, is owned by the Developer and is protected by copyright and other intellectual property laws. Clinical formulations, constants, and published methods implemented in the App remain the property of their respective sources and are used for reference and educational purposes. Third-party trademarks referred to in the App remain the property of their respective owners, as set out in section 4.
The App is provided free of charge. We are under no obligation to provide support, maintenance, updates, corrections, or continued availability, and may modify, suspend, or discontinue the App at any time without notice. Support enquiries may be directed to the address in section 17, without any commitment as to response or resolution.
THE APP IS PROVIDED "AS IS" AND "AS AVAILABLE", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, WE DISCLAIM ALL WARRANTIES, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. WE DO NOT WARRANT THAT THE APP WILL MEET YOUR REQUIREMENTS, THAT ITS OPERATION WILL BE UNINTERRUPTED OR ERROR-FREE, OR THAT ANY OUTPUT WILL BE ACCURATE OR RELIABLE.
SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF CERTAIN WARRANTIES, SO SOME OF THE ABOVE EXCLUSIONS MAY NOT APPLY TO YOU.
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL THE DEVELOPER BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE DAMAGES, OR FOR ANY PERSONAL INJURY, DEATH, LOSS OF DATA, LOSS OF PROFITS, OR BUSINESS INTERRUPTION, ARISING OUT OF OR RELATING TO YOUR USE OF OR INABILITY TO USE THE APP, HOWEVER CAUSED AND UNDER ANY THEORY OF LIABILITY, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE DEVELOPER'S TOTAL AGGREGATE LIABILITY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE APP SHALL NOT EXCEED FIFTY UNITED STATES DOLLARS (US$50).
SOME JURISDICTIONS DO NOT ALLOW THE LIMITATION OR EXCLUSION OF LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES OR FOR PERSONAL INJURY, SO SOME OF THE ABOVE LIMITATIONS MAY NOT APPLY TO YOU. NOTHING IN THIS AGREEMENT LIMITS LIABILITY THAT CANNOT BE LIMITED UNDER APPLICABLE LAW.
You agree to indemnify, defend, and hold harmless the Developer from and against any claims, liabilities, damages, losses, and expenses, including reasonable legal fees, arising out of or in any way connected with your use of the App, your breach of this Agreement, your violation of any law or professional obligation, or any clinical decision made by you or on your direction.
This Agreement is effective until terminated. It terminates automatically without notice if you fail to comply with any of its terms. You may terminate it at any time by deleting the App from your device. Sections 4, 6, 7, and 9 through 16 survive termination.
This Agreement is governed by the laws of the State of Georgia, United States, without regard to its conflict-of-laws principles. You agree that the state and federal courts located in the State of Georgia have exclusive jurisdiction over any dispute arising out of or relating to this Agreement or the App, and you consent to personal jurisdiction and venue in those courts.
Nothing in this section deprives you of the protection of mandatory consumer-protection provisions of the law of the jurisdiction in which you reside, where those provisions cannot be varied by agreement.
The following terms apply because the App is distributed through the Apple App Store. You acknowledge and agree that:
If any provision of this Agreement is held unenforceable, that provision will be limited or severed to the minimum extent necessary and the remaining provisions will remain in full force. Our failure to enforce any provision is not a waiver of it. This Agreement is the entire agreement between you and the Developer regarding the App.
We may revise this Agreement; the current version will always be posted at this address with its effective date. Continued use of the App after a revision constitutes acceptance of the revised Agreement.
Contact: y90app@gmail.com